Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $10,452 | 6 | 69.6% |
| Food and Beverage | $3,306 | 127 | 22.0% |
| Travel and Lodging | $1,268 | 6 | 8.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $7,174 | 4 | $0 (2021) |
| Abbott Laboratories | $6,341 | 68 | $0 (2024) |
| Allergan, Inc. | $532.58 | 34 | $0 (2020) |
| Novo Nordisk AS | $400.00 | 1 | $0 (2019) |
| Lilly USA, LLC | $136.20 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $126.28 | 1 | $0 (2018) |
| AbbVie Inc. | $86.73 | 6 | $0 (2021) |
| Radius Health, Inc. | $63.79 | 4 | $0 (2019) |
| Novo Nordisk Inc | $41.65 | 2 | $0 (2024) |
| Medtronic Vascular, Inc. | $31.36 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,980 | 34 | Abbott Laboratories ($1,919) |
| 2023 | $740.06 | 12 | Abbott Laboratories ($740.06) |
| 2022 | $213.42 | 17 | Abbott Laboratories ($213.42) |
| 2021 | $7,263 | 15 | Eli Lilly and Company ($6,960) |
| 2020 | $242.08 | 13 | Allergan, Inc. ($187.64) |
| 2019 | $688.69 | 10 | Novo Nordisk AS ($400.00) |
| 2018 | $3,568 | 14 | Abbott Laboratories ($3,278) |
| 2017 | $331.42 | 24 | Allergan Inc. ($150.09) |
All Payment Transactions
139 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Abbott Laboratories | ADVISOR (Device) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: Electrophysiology | ||||||
| 12/04/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $242.56 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/04/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $231.16 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/04/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $210.27 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/04/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $195.58 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/01/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $379.82 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/01/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Structural Heart | ||||||
| 11/01/2024 | Abbott Laboratories | AVEIR (Device) | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/25/2024 | Abbott Laboratories | ASSURITY (Device) | Food and Beverage | In-kind items and services | $2.16 | General |
| Category: Cardiac Rhythm Management | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | GILOTRIF (Drug) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2024 | Abbott Laboratories | ABSOLUTE PRO (Device) | Food and Beverage | In-kind items and services | $50.32 | General |
| Category: Vascular | ||||||
| 10/02/2024 | Abbott Laboratories | NA (Device) | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: Electrophysiology | ||||||
| 09/11/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Cardiac Rhythm Management | ||||||
| 08/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Abbott Laboratories | VIEWMATE (Device) | Food and Beverage | In-kind items and services | $8.11 | General |
| Category: Electrophysiology | ||||||
| 08/27/2024 | Abbott Laboratories | TACTICATH ABLATION CATHETER, SENSOR ENABLED (Device) | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: Electrophysiology | ||||||
| 08/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Structural Heart | ||||||
| 07/23/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: Structural Heart | ||||||
| 07/19/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Structural Heart | ||||||
| 07/12/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $188.85 | General |
| Category: Structural Heart | ||||||
| 07/11/2024 | Abbott Laboratories | NA (Device) | Food and Beverage | In-kind items and services | $7.23 | General |
| Category: Electrophysiology | ||||||
| 07/10/2024 | Abbott Laboratories | AMPLATZER AMULET (Device) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Structural Heart | ||||||
| 05/22/2024 | Abbott Laboratories | VIEWMATE (Device) | Food and Beverage | In-kind items and services | $8.39 | General |
| Category: Electrophysiology | ||||||
| 05/03/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $29.02 | General |
| Category: Cardiac Rhythm Management | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3B, RANDOMIZED, DOUBLE-BLIND, PARALLEL-ARM, PLACEBO- AND ACTIVE- CONTROLLED TREAT-THROUGH STUDY OF MIRIKIZUMAB AND VEDOLIZUMAB IN PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS | Eli Lilly and Company | $6,960 | 1 |
| MultiPoint Pacing Post Market Study | Abbott Laboratories | $3,278 | 2 |
| A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL, PLACEBO-CONTROLLED INDUCTION STUDY OF MIRIKIZUMAB IN CONVENTIONAL-FAILED AND BIOLOGIC-FAILED PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (LUCENT 1) | Eli Lilly and Company | $185.58 | 2 |
| A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-ARM, PLACEBO-CONTROLLED MAINTENANCE STUDY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (LUCENT 2) | Eli Lilly and Company | $28.24 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 67 | 177 | $18,715 | $14,268 |
| 2022 | 3 | 60 | 147 | $15,648 | $11,016 |
| 2021 | 3 | 72 | 217 | $23,958 | $17,794 |
| 2020 | 5 | 500 | 1,285 | $111,693 | $70,834 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 135 | $15,665 | $11,280 | 72.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 21 | 21 | $2,647 | $2,594 | 98.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 21 | 21 | $402.99 | $395.01 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 117 | $13,577 | $8,969 | 66.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 14 | 14 | $1,765 | $1,743 | 98.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 16 | 16 | $307.04 | $303.24 | 98.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 179 | $20,771 | $14,607 | 70.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 23 | 23 | $2,899 | $2,899 | 100.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 15 | 15 | $287.85 | $287.85 | 100.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 134 | 422 | $48,969 | $30,159 | 61.6% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 158 | 531 | $24,129 | $15,849 | 65.7% |
| 99335 | Established patient assisted living visit, typically 25 minutes | Office | 2020 | 138 | 259 | $26,664 | $14,594 | 54.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 51 | 51 | $6,428 | $6,340 | 98.6% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 19 | 22 | $5,504 | $3,892 | 70.7% |
About Dr. Jorge Diaz, D.O
Dr. Jorge Diaz, D.O is a Internal Medicine healthcare provider based in Hialeah, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346279809.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jorge Diaz, D.O has received a total of $15,027 in payments from pharmaceutical and medical device companies, with $1,980 received in 2024. These payments were reported across 139 transactions from 15 companies. The most common payment nature is "" ($10,452).
As a Medicare-enrolled provider, Diaz has provided services to 699 Medicare beneficiaries, totaling 1,826 services with total Medicare billing of $113,912. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Hialeah, FL
- Active Since 06/30/2006
- Last Updated 10/03/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346279809
Products in Payments
- CRM-Research Only (Device) $3,278
- AVEIR (Device) $1,895
- AMPLATZER AMULET (Device) $463.49
- UBRELVY (Drug) $215.46
- BYSTOLIC (Drug) $153.67
- TACTICATH ABLATION CATHETER, SENSOR ENABLED (Device) $148.27
- EnSite Precision Cardiac Mapping System (Device) $127.32
- ENTRESTO (Drug) $126.28
- FORTEO (Drug) $121.18
- MERLIN@HOME (Device) $94.52
- LINZESS (Drug) $86.38
- ASSURITY (Device) $78.83
- Tymlos (Biological) $63.79
- NAMZARIC (Drug) $60.90
- CONFIRM RX (Device) $56.60
- ABSOLUTE PRO (Device) $50.32
- VRAYLAR (Drug) $44.49
- Merlin Connectivity and Remote (Device) $44.26
- JOT DX (Device) $44.11
- VIBERZI (Drug) $43.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hialeah
Miguel Diaz, Md, MD
Internal Medicine — Payments: $472,891
Karelia Ruiz
Internal Medicine — Payments: $114,006
Dr. Francisco Rosas, M.d, M.D
Internal Medicine — Payments: $105,387
Dr. Miguel Perez, M.d, M.D
Internal Medicine — Payments: $86,695
Dr. William Sanchez, M.d, M.D
Internal Medicine — Payments: $16,197
Dr. Scott Halperin, M.d, M.D
Internal Medicine — Payments: $14,253